Commission Regulation (EU) No 823/2012 of 14 September 2012 derogating from Implementing Regulation (EU) No 540/2011 as regards the expiry dates of the approval of the active substances 2,4-DB, benzoic acid, beta-cyfluthrin, carfentrazone ethyl, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), cyazofamid, cyfluthrin, deltamethrin, dimethenamid-P, ethofumesate, ethoxysulfuron, fenamidone, flazasulfuron, flufenacet, flurtamone, foramsulfuron, fosthiazate, imazamox, iodosulfuron, iprodione, isoxaflutole, linuron, maleic hydrazide, mecoprop, mecoprop-P, mesosulfuron, mesotrione, oxadiargyl, oxasulfuron, pendimethalin, picoxystrobin, propiconazole, propineb, propoxycarbazone, propyzamide, pyraclostrobin, silthiofam, trifloxystrobin, warfarin and zoxamide
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
204/2014 In force in the EEA
Yes Legal documents
Commission Regulation (EU) No 823/2012 of 14 September 2012 derogating from Implementing Regulation (EU) No 540/2011 as regards the expiry dates of the approval of the active substances 2,4-DB, benzoic acid, beta-cyfluthrin, carfentrazone ethyl, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), cyazofamid, cyfluthrin, deltamethrin, dimethenamid-P, ethofumesate, ethoxysulfuron, fenamidone, flazasulfuron, flufenacet, flurtamone, foramsulfuron, fosthiazate, imazamox, iodosulfuron, iprodione, isoxaflutole, linuron, maleic hydrazide, mecoprop, mecoprop-P, mesosulfuron, mesotrione, oxadiargyl, oxasulfuron, pendimethalin, picoxystrobin, propiconazole, propineb, propoxycarbazone, propyzamide, pyraclostrobin, silthiofam, trifloxystrobin, warfarin and zoxamide
Reglugerð framkvæmdastjórnarinnar (ESB) nr. 823/2012 frá 14. september 2012 um að víkja frá framkvæmdarreglugerð (ESB) nr. 540/2011 að því er varðar lokadag samþykkis fyrir virku efnunum 2,4-DB, bensósýru, betasýflútríni, karfentrasónetýli, Coniothyrium minitans af stofni CON/M/91-08 (DSM 9660), sýasófamíði, sýflútríni, deltametríni, dímetenamíði-P, etófúmesati, etoxýsúlfúróni, fenamídóni, flasasúlfúróni, flúfenaseti, flúrtamóni, fóramsúlfúróni, fosþíasati, ímasamoxi, ídósúlfúróni, ípródíóni, ísoxaflútóli, línúróni, malínhýdrasíði, mekóprópi, mekóprópi-P, mesósúlfúróni, mesótríóni, oxadíargýli, oxasúlfúróni, pendímetalíni, píkoxýstróbíni, própíkónasóli, própínebi, própoxýkarbasóni, própýsamíði, pýraklóstróbíni, silþíófami, trífloxýstróbíni, varfaríni og soxamíði
Verordnung (EU) Nr. 823/2012 der Kommission vom 14. September 2012 zur Festlegung von von der Durchführungsverordnung (EU) Nr. 540/2011 abweichenden Fristen für die Genehmigung der Wirkstoffe 2,4-DB, Benzoesäure, beta-Cyfluthrin, Carfentrazon-ethyl, Coniothyrium minitans Stamm CON/M/91-08 (DSM 9660), Cyazofamid, Cyfluthrin, Deltamethrin, Dimethenamid-P, Ethofumesat, Ethoxysulfuron, Fenamidon, Flazasulfuron, Flufenacet, Flurtamon, Foramsulfuron, Fosthiazat, Imazamox, Iodosulfuron, Iprodion, Isoxaflutol, Linuron, Maleinsäurehydrazid, Mecoprop, Mecoprop-P, Mesosulfuron, Mesotrion, Oxadiargyl, Oxasulfuron, Pendimethalin, Picoxystrobin, Propiconazol, Propineb, Propoxycarbazon, Propyzamid, Pyraclostrobin, Silthiofam, Trifloxystrobin, Warfarin und Zoxamid
Kommisjonsforordning (EU) nr. 823/2012 av 14. september 2012 om unntak fra gjennomføringsforordning (EU) nr. 540/2011 med hensyn til utløpsdatoene for godkjenning av de aktive stoffene 2,4-DB, benzosyre, beta-cyflutrin, karfentrazon-etyl, Coniothyrium minitans stamme CON/M/91-08 (DSM 9660), cyazofamid, cyflutrin, deltametrin, dimetenamid-P, etofumesat, etoksysulfuron, fenamidon, flazasulfuron, flufenacet, flurtamon, foramsulfuron, fostiazat, imazamox, jodsulfuron, iprodion, isoksaflutol, linuron, maleinhydrasid, mekoprop, mekoprop-P, mesosulfuron, mesotrion, oksadiargyl, oksasulfuron, pendimetalin, pikoksystrobin, propikonazol, propineb, propoksykarbason, propyzamid, pyraklostrobin, siltiofam, trifloksystrobin, warfarin og zoksamid
History
01.06.2015
Adopted JCD confirmed entry into force date
01.06.2015
Compliance date in the EEA
30.09.2014
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
16.12.2013
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
14.09.2012
Adoption date in the EU
16.09.2012
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.